Xingyiang Bio
星奕昂生物
Xingyiang Bio
Biotech/Healthcare
Xingyiang Biotechnology Co., Ltd. focuses on the research, development, and commercialization of immune cell therapies.
Latest round: Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.